Search Results

Your search for Christopher Rose, MD, FASTRO, and Allen S. Lichter, MD, FASTRO, FASCO matches 2 pages

Showing 1 - 2

By Christopher Rose, MD, FASTRO, and Allen S. Lichter, MD, FASTRO, FASCO / July 10, 2022

History of Radiation Oncology in the United States

Part 1 of this two-part report described the beginnings of radiation oncology in the United States, including many of the field’s early pioneers and the rise of associated professional societies. In part 2, we will consider the advances in technology and biology that are the foundation of modern...

issues in oncology

By Christopher Rose, MD, FASTRO and Allen S. Lichter, MD, FASTRO, FASCO / June 25, 2022

History of Radiation Oncology in the United States

Radiation therapy has long been one of the three pillars of cancer therapy—surgery, chemotherapy, and radiotherapy—only recently joined by what is widely considered a fourth pillar, immunotherapy. In part 1 of this two-part report, we trace the beginnings of radiation oncology in the United...

Nov

Today In Oncology

Search Results

Your search for Christopher Rose, MD, FASTRO, and Allen S. Lichter, MD, FASTRO, FASCO matches 2 pages

History of Radiation Oncology in the United States

History of Radiation Oncology in the United States

Firefighters May Be Exposed to Chemicals Associated With Breast Cancer

FDA Grants Accelerated Approval to Zanidatamab-hrii for Previously Treated Unresectable or Metastatic HER2-Positive Biliary Tract Cancer

Novel EGFR Inhibitor Firmonertinib Shows Activity in Rare Subtype of NSCLC

Outcomes of Immune Checkpoint Inhibitor Treatment for Cancer in Black vs White Patients in the U.S. VHA System

Pooled Analysis of Long-Term Outcomes With Nivolumab With or Without Ipilimumab in Advanced Melanoma